Targeting CD6 for the treatment of experimental autoimmune uveitis

OBJECTIVE: CD6 is emerging as a new target for treating many pathological conditions in which T cells are integrally involved, but even the latest data from studies of CD6 gene engineered mice were still contradictory. To address this issue, we studied experimental autoimmune uveitis (EAU), a model...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Autoimmun
Egile Nagusiak: Zhang, Lingjun, Li, Yan, Qiu, Wen, Bell, Brent A, Dvorina, Nina, Baldwin, William M., Singer, Nora, Kern, Timothy, Caspi, Rachel R, Fox, David A, Lin, Feng
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5949263/
https://ncbi.nlm.nih.gov/pubmed/29472120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaut.2018.02.004
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak